Anti-tissue transglutaminase antibodies (t-TG), mostly IgA class, is considered to be the most specific serological immune response in coeliac disease, and is associated with enteropathy, specific Ig A class antibody against t-TG being found at the intestinal level (1, 2) .
The results show negative IgA class t-TG is expected in about 10 % of patients with coeliac disease who are < 2 years of age. Furthermore, no Ig G response is to be expected in those patients. It can be speculated that the immature development of the immune system slowly responding to gluten exposure delays the appearance of autoimmunity. This notion would be in keeping with reports of no IgA t-TG antibodies deposited at the intestinal level in younger patients (3) (4) (5) . Moreover, the data confirm the response against gliadin is the immunological trigger in coeliac disease.
